Paperpal Prime Logo

Expert Opinion on Drug Discovery : Impact Factor & More

eISSN: 1746-045XpISSN: 1746-0441

Aims and Scope of Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery is a monthly peer-reviewed medical journal publishing review articles on novel technologies involved in drug discovery. The editor-in-chief is David Janero from Northeastern University. Less

Key Metrics

CiteScore
8.5
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Drug Discovery
SNIP
1.17
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Drug Discovery

Expert Opinion on Drug Discovery Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Bi-monthly
General Details
LanguageEnglish
FrequencyBi-monthly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Drug Discovery ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Drug Discovery

Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications
  • 9 Aug 2026
  • Expert Opinion on Drug Discovery
Mössbauer spectroscopy in drug discovery: revealing Fe- and Fe-S cluster dependent targets
  • 8 Aug 2026
  • Expert Opinion on Drug Discovery
Should C. elegans play a larger role in drug discovery for neurodegenerative diseases?
  • 7 Aug 2026
  • Expert Opinion on Drug Discovery
An overview of the current animal models of Marburg virus disease for countermeasure development
  • 6 Aug 2026
  • Expert Opinion on Drug Discovery
Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology
  • 3 Aug 2026
  • Expert Opinion on Drug Discovery
Radiolysis in drug discovery: molecular modification, repurposing, and mechanistic insights
  • 3 Aug 2026
  • Expert Opinion on Drug Discovery
Foundation models for low-data drug discovery: mining heterogeneous public and proprietary data in neglected indications
  • 9 Aug 2026
  • Expert Opinion on Drug Discovery
Mössbauer spectroscopy in drug discovery: revealing Fe- and Fe-S cluster dependent targets
  • 8 Aug 2026
  • Expert Opinion on Drug Discovery
Should C. elegans play a larger role in drug discovery for neurodegenerative diseases?
  • 7 Aug 2026
  • Expert Opinion on Drug Discovery
An overview of the current animal models of Marburg virus disease for countermeasure development
  • 6 Aug 2026
  • Expert Opinion on Drug Discovery
Toward a nuanced framework for the medical development of ibogaine and its analogues and derivatives: implications for psychopharmacology
  • 3 Aug 2026
  • Expert Opinion on Drug Discovery
Radiolysis in drug discovery: molecular modification, repurposing, and mechanistic insights
  • 3 Aug 2026
  • Expert Opinion on Drug Discovery

FAQs on Expert Opinion on Drug Discovery